% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • nowwheretogo22004 nowwheretogo22004 May 11, 2012 7:37 AM Flag

    •Phase III protocol for endometriosis finalized

    You got that right! The solvency issues in Europe are killing the market. With Abbott releasing the clinical trial design on sometime within the 3 or 4 days, we have a chance to get some more new interest in the stock. It would be from people who follow Abbott instead of NBIX.

    NBIX has plenty of cash and a maturing pipeline, so we can wait it out and let the results speak for themselves. It just should be worth so much more than it is now.

50.15-0.67(-1.32%)Jul 28 4:00 PMEDT